| 中文名称 | (1R,2R,4R)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-二羟基-10,21-二甲氧基-6,8,12,14,20,26-六甲基-1,5,1,28,29-五氧代-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-二十四氢-3H-23,27-环氧吡啶并[2,1-c][1]氧杂[4]氮杂环三十一碳烷-3-基)丙基)- |
|---|---|
| 中文别名 | 西罗莫司脂化物;替西罗莫司;1,1-二氯-1-氟乙烷;Temsirolimus 抑制剂;坦西莫司;西罗莫司;西罗莫司脂化物 Temsirolimus;西罗莫司脂化物标准品;西罗莫司酯化物;雷帕霉素;坦罗莫司;雷帕霉素42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯];替西莫司;替西罗莫;坦西莫司(替西罗莫司);坦罗莫司(替西罗莫司);坦西莫司, 西罗莫司脂化物 |
| 英文名称 | (1R,2R,4R)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epo |
| 英文别名 | Temsirolimus;Temsirolimus (CCI-779, NSC 683864);42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]Rapamycin;Temsirolimus (cell cycle inhibitor 779,CCI-779,Torisel®);[14C]-Temsirolimus;CCI779;CCL-779;Rapamycin (42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate];rapaMycin 42-ester with 3-hydroxy-2-(hydroxyMethyl)-2-Methylpropionic acid;TeMsiroliMus (~);TeMsiroliMus (CCI-779,Torisel);TeMsiroliMus (Torisel);CCI-779;Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate];C15182;NSC 683864;Temsirolimus(CCI-779);Torisel;624KN6GM2T;42-[3-Hydroxy-2-methylpropanoate;Cci 779;Temserolimus;Temsirolimus - Torisel;Rapamycin 42-(2,2-bis(hydroxymethyl)propionate);DSSTox_CID_20945;DSSTox_RID_79605;DSSTox_GSID_40945;42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin;Rapamycin 42-[3-hydroxy-2-(hydroxym |
| CAS号 | 162635-04-3 |
| 分子式 | C56H87NO16 |
| 分子量 | 1030.29 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
